Multivariate analysis indicated that MSS (p = 0.004), higher T stage (p = 0.005), lymph node metastasis (p = 0.013), and LC3B+ expression (p = 0.025) were independent prognostic factors (Table 6). The gene discussed is MAP1LC3B; the disease is metastatic malignant neoplasm in the lymph nodes.